Prognosis

Hunting for Tech Ties, a Swiss Drugmaker Goes to Silicon Valley

Novartis launches innovation labs, starting in San Francisco
New project will be called the Biome, digital chief says

An illuminated logo sits outside Novartis AG's headquarters in Basel, Switzerland, on Tuesday, July, 16, 2013. Novartis AG raised its profit and sales forecasts as generic competition for the Diovan blood-pressure medicine failed to materialize in the U.S.Photographer: Gianluca Colla/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By James Paton

October 9, 2018 at 1:00 AM UTC

Updated on

October 9, 2018 at 9:00 AM UTC

This article is for subscribers only.

Novartis AG is looking to strengthen its ties with tech startups as giants like Apple Inc., Google and Amazon.com Inc. advance rapidly into the health-care field.

The Swiss drugmaker is setting up innovation labs in cities around the world, starting with San Francisco, Chief Digital Officer Bertrand Bodson said in a phone interview. As part of the new project called the Novartis Biome, the company is collaborating with outfits including Mekonos, a developer of cell- and gene-therapy technology, and Medable, a digital health firm. Both are based in the Silicon Valley town of Palo Alto, California.